Correlation Between Milestone Pharmaceuticals and Scpharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and Scpharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and Scpharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and Scpharmaceuticals, you can compare the effects of market volatilities on Milestone Pharmaceuticals and Scpharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of Scpharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and Scpharmaceuticals.
Diversification Opportunities for Milestone Pharmaceuticals and Scpharmaceuticals
-0.51 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Milestone and Scpharmaceuticals is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and Scpharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Scpharmaceuticals and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with Scpharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Scpharmaceuticals has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and Scpharmaceuticals go up and down completely randomly.
Pair Corralation between Milestone Pharmaceuticals and Scpharmaceuticals
Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to generate 0.95 times more return on investment than Scpharmaceuticals. However, Milestone Pharmaceuticals is 1.06 times less risky than Scpharmaceuticals. It trades about 0.26 of its potential returns per unit of risk. Scpharmaceuticals is currently generating about -0.2 per unit of risk. If you would invest 147.00 in Milestone Pharmaceuticals on August 24, 2024 and sell it today you would earn a total of 38.00 from holding Milestone Pharmaceuticals or generate 25.85% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Milestone Pharmaceuticals vs. Scpharmaceuticals
Performance |
| Timeline |
| Milestone Pharmaceuticals |
| Scpharmaceuticals |
Milestone Pharmaceuticals and Scpharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Milestone Pharmaceuticals and Scpharmaceuticals
The main advantage of trading using opposite Milestone Pharmaceuticals and Scpharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, Scpharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scpharmaceuticals will offset losses from the drop in Scpharmaceuticals' long position.The idea behind Milestone Pharmaceuticals and Scpharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Scpharmaceuticals vs. Lyra Therapeutics | Scpharmaceuticals vs. Hookipa Pharma | Scpharmaceuticals vs. Cingulate Warrants | Scpharmaceuticals vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |